The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review
2020 ◽
2020 ◽
Vol 21
(2)
◽
pp. 106-113.e5
◽
2017 ◽
Vol 12
(11)
◽
pp. S2150
◽